Cor Vasa 2021, 63(5):555-563 | DOI: 10.33678/cor.2021.046

Oxidative stress, depression, and risk of recurrence of stable coronary heart disease

Tarass Ivascenkoa, Vladimirs V. Voicehovskisa, Julija G. Voicehovskaa, Andrejs Skestersa, Ketija Apsitea, Julija Grigorjevaa, Anda Kivite-Urtanea, Natalija Pahomovab, Oskars Kalejsa
a Rigas Stradins university, Dzirciema str. 16, Riga LV-1007, Latvia
b "Medsport", Liela str. 19-2a, Riga LV-1016, Latvia

Aim: The aim of the study was to investigate the relationships between a level of oxidative stress (OS), depression (D) and risk of recurrence of stable coronary heart disease (SCHD).

Methods: A retrospective study was conducted on 174 participants, at the age 45+ years: 86 in-patients of the cardiology department with a recurrent SCHD and 88 in-patients of the cardiology department with primary SCHD. The severity of depressive symptoms was assessed using the long 30-item form of Geriatric Depression Scale (GDS), valid Latvian version of GDS-LAT. The blood samples were taken from each patient to measure oxidative stress parameters malondialdehyde (MDA) and glutathione peroxidase (GPx).

Results: 83.9% of the sample had high level of MDA. In 72.4% of the sample the GPx level was normal, in 17.8% it was high and in 9.8% low. Slightly more than a half of the patients were experiencing depression (44.3% - mild D and 6.9% - severe D). GPx was found statistically differing between primary and recurrent SCHD (p = 0,003). Patients with both D and high GPx had 10.6 times higher chances of recurrent SHCD compared to those without D and normal GPx (p = patients with present D were experiencing both - high levels of MDA and GPx – more often than responders with no D, but this wasn’t statistically signifi cant [p = 0.51]).

Conclusion: In the present study it was found that level of antioxidant (AO) enzyme GPx was signifi cantly higher in depressed patients with recurrent SCHD compared to patients without D and to patients with primary SCHD and patients with both D and high GPx had higher chances of recurrent SCHD compared to those without D and normal GPx. It could be supposed that GPx is a more signifi cant marker of risk of D and  recurrence of SCHD. The high level of MDA in most of both (primary and recurrent SCHD) groups patients could evidence that increased OS is a risk factor for CHD in general. Monitoring OS biomarkers seems to be important in the management of SCHD comorbidity with D. Further studies are warranted to confi rm these findings.

Keywords: Depression, GPx, Geriatric depression scale, MDA, Oxidative stress, Stable coronary heart disease

Received: March 18, 2021; Revised: March 18, 2021; Accepted: April 3, 2021; Published: October 20, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ivascenko T, Voicehovskis VV, Voicehovska JG, Skesters A, Apsite K, Grigorjeva J, et al.. Oxidative stress, depression, and risk of recurrence of stable coronary heart disease. Cor Vasa. 2021;63(5):555-563. doi: 10.33678/cor.2021.046.
Download citation

References

  1. Lin D, Wang L, Yan S, et al. The Role of Oxidative Stress in Common Risk Factors and Mechanisms of Cardio-Cerebrovascular Ischemia and Depression. Oxid Med Cell Longev 2019;2019:2491927. Go to original source... Go to PubMed...
  2. Cardiovascular diseases. World Health Organization 2017 May [cited 2020 May 5]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) Go to PubMed...
  3. World Health Organization. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization, 2011.
  4. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med 2016;4:256. Go to original source... Go to PubMed...
  5. Huffman JC, Celano CM, Beach SR, et al. Depression and Cardiac Disease: Epidemiology, Mechanisms, and Diagnosis. Cardiovasc Psychiatry Neurol 2013;2013:1-14. Go to original source... Go to PubMed...
  6. Whooley MA, Wong JM. Depression and cardiovascular disorders. Annu Rev Clin Psychol 2013;9:327-354. Go to original source... Go to PubMed...
  7. Hert MD, Detraux J, Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin Neurosci 2018;20:31-39. Go to original source... Go to PubMed...
  8. Van der Kooy K, van Hout H, Marwijk H, et al. Depression and the risk for cardiovascular diseases: Systematic review and meta analysis. Int J of Geriatr Psychiatry 2007;22:613-626. Go to original source... Go to PubMed...
  9. Guck TP, Kavan MG, Elsasser GN, Barone EJ. Assessment and treatment of depression following myocardial infarction. Am Fam Physician 2001;64:641-647. Go to PubMed...
  10. Moryś M, Bellwon J, Adamczyk K, Gruchala M. Depression and anxiety in patients with coronary artery disease, measured by means of self-report measures and clinician-rated instrument. Kardiol Pol 2016;74:53-60. Go to original source... Go to PubMed...
  11. Celano CM, Huffman JC. Depression and cardiac disease: a review. Cardiol Rev 2011;19:130-142. Go to original source... Go to PubMed...
  12. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004;66:802-813. Go to original source... Go to PubMed...
  13. Januzzi JL, Stern TA, Pasternak RC, DeSanctis RW. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000;160:1913-1921. Go to original source... Go to PubMed...
  14. Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the EnhancingRecovery in Coronary Heart Disease (ENRICHD) study 2004. Psychosom Med 2004;66:466-474. Go to original source... Go to PubMed...
  15. Van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004;66:814-822. Go to original source... Go to PubMed...
  16. Chauvet-Géliniera JC, Trojaka B, Vergès-Patois B, et al. Review on depression and coronary heart disease. Arch Cardiovasc Dis 2013;106:103-110. Go to original source... Go to PubMed...
  17. Trebatická J, Dukát A, Ďuračková Z. Cardiovascular Diseases, Depression Disorders and Potential Effects of Omega-3 Fatty Acids. Physiol Res 2017;66:363-382. Go to original source... Go to PubMed...
  18. Vaváková M, Ďuračková Z, Trebatická J. Markers of Oxidative Stress and Neuroprogression in Depression Disorder. Oxid Med Cell Longev 2015;2015:898393. Go to original source... Go to PubMed...
  19. Kander MC, Cui Y, Liu Z. Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med 2017;21:1024-1032. Go to original source... Go to PubMed...
  20. Adifbair A, Saleem M, Lanctôt KL, Herrmann N. Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review. Curr Mol Med 2016;16:137-164. Go to original source... Go to PubMed...
  21. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malonaldehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005;15:316-328. Go to original source... Go to PubMed...
  22. Mazereeuw G, Herrmann N, Andreazza AC, et al. Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients. Brain Behav Immun 2017;60:136-141. Go to original source... Go to PubMed...
  23. Vichova T, Motovska Z. Oxidative stress: Predictive marker for coronary artery disease. Exp Clin Cardiol 2013;18:e88-e91.
  24. Frey BV, Valvassori SS, Réus GZ, et al. Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem Res 2006:31:699-703. Go to original source... Go to PubMed...
  25. Liu T, Zhong Z, Liao X, et al. A Meta-Analysis of Oxidative Stress Markers in Depression. PLoS ONE 2015;10:e0138904. Go to original source... Go to PubMed...
  26. Cumurcu BE, Ozyurt H, Etikan I, et al. Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin Neurosci 2009;63:639-645. Go to original source... Go to PubMed...
  27. Hasnain M, Vieweg WVR, Lesnefsky EJ, Pandurangi AK. Depression screening in patients with coronary heart disease: a critical evaluation of the AHA guidelines. J Psychosom Res 2011;71:6-12. Go to original source... Go to PubMed...
  28. Yesavage AB. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983;17:37-49. Go to original source... Go to PubMed...
  29. Voicehovskis VM. Validation of the Latvian version of the Geriartric Depression Scale (GDS). Psychother Psychosom 2013;82:122-123.
  30. Armstrong D, Browne R. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 1994;366:43-58. Go to original source... Go to PubMed...
  31. Armstrong D. Free Radicals and Antioxidant Protocols. Methods Mol Biol 1998;108:315-324. Go to original source...
  32. Boyum A. OxiSelect TBARS Assay Kit (MDA Quantitation). J Clin Invest 1966;21:S97.
  33. Paglia DV. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
  34. Bauer LK, Caro MA, Beach SR, et al. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol 2012;109:1266-1271. Go to original source... Go to PubMed...
  35. Pezeshkian M, Nouri M, Zahraei M, et al. Study of MDA, antioxidant vitamins, lipoproteins serum levels and anthropome-try parameters in coronary artery disease patients. Med J Islamic World Acad Sci 2001;14:5-8.
  36. Kaya Y, Çebi A, Söylemez N, Demir H, et al. Correlations between Oxidative DNA Damage, Oxidative Stress and Coen-zyme Q10 in Patients with Coronary Artery Disease. Int J Med Sci 2012;9:621-626. Go to original source... Go to PubMed...
  37. Cheraghi M, Ahmadvand H, Ali Maleki A, et al. Oxidative Stress Status and Liver Markers in Coronary Heart Disease. Rep Biochem Mol Biol 2019;8:49-55.
  38. Vaváková M, Trebatická J, Dukát A, et al. Cardiovascular Diseases, Depression Disorders and Potential Effects of Omega-3 Fatty Acids. Physiol Res 2017;66:363-382. Go to original source... Go to PubMed...
  39. Nakamura K, Murakami M, Miura D, et al. Beta-Blockers and Oxidative Stress in Patients with Heart Failure. Pharmaceuticals 2011;4:1088-1100. Go to original source... Go to PubMed...
  40. Kukin ML, Kalman J, Charney RH, et al. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Pharmaceuticals 2011;4:1099.
  41. Yekehtaz H, Farokhnia M, Akhondzadeh S. Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review. J Tehran Heart Cent 2013;8:169-176.
  42. Nezafati MH, Vojdanparast M, Nezafati P. Antidepressants and cardiovascular adverse events: A narrative review. Atherosc 2015;11:295.
  43. Pinchuk I, Weberb D, Kochlikb B, et al. Gender- and age-dependencies of oxidative stress, as detected based on the steady state concentrations of different biomarkers in the MARK-AGE study. Redox Biology 2019;24:1-7. Go to original source... Go to PubMed...
  44. Ito F, Yoko Sono Y, Ito T. Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation. Antioxidants 2019;8:72. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.